Yes, you can and should refer a patient with frozen shoulder for a corticosteroid injection
Intra-articular corticosteroid injection is an effective treatment for frozen shoulder (adhesive capsulitis) that provides significant pain relief and functional improvement, particularly when administered early in the disease course.
Evidence-Based Rationale
The research evidence strongly supports corticosteroid injection for frozen shoulder, despite the absence of specific guideline recommendations for this condition (the guidelines you might find address glenohumeral osteoarthritis, not adhesive capsulitis—these are different conditions).
Efficacy Profile
Pain Relief:
- Significant reduction in pain at 4-6 weeks, 12-16 weeks, and effects lasting up to 24-26 weeks 1
- Faster pain relief compared to oral NSAIDs, with significant differences observed within the first 8 weeks 2
- Superior short-term pain relief compared to suprascapular nerve block 3
Functional Improvement:
- Improved SPADI scores (Shoulder Pain and Disability Index) when combined with physical therapy—17.52 points greater improvement than PT alone 4
- Enhanced passive range of motion in flexion, abduction, and external rotation 1
- ASES (American Shoulder and Elbow Surgeons) scores improved at 12-16 weeks 1
Timing Matters Critically
Stage 1 (Early/Freezing Phase):
- 100% of patients met recovery criteria for forward flexion and internal rotation
- Recovery time: 2-6 weeks 5
Stage 2 (Frozen Phase):
- 60-72% met recovery criteria across ROM planes
- Recovery time: 7-10 weeks 5
The key clinical implication: inject early. Patients treated in Stage 1 recover significantly faster than those treated in Stage 2.
Practical Implementation
Dosing
Low-dose corticosteroid (20 mg triamcinolone acetonide) is as effective as high-dose (40 mg) 6. Use the lower dose to minimize systemic effects.
Injection Technique
- Ultrasound guidance is preferable for accurate glenohumeral joint placement 7
- Intra-articular injection provides superior short-term pain relief compared to suprascapular notch injection 3
- Landmark-guided injection is acceptable if ultrasound unavailable, though accuracy is lower
Combined Approach
The injection should be paired with physical therapy. The combination provides significantly better outcomes than either intervention alone 4. The corticosteroid reduces inflammation and pain, allowing more effective participation in rehabilitation.
Enhanced Options
For more severe cases, consider corticosteroid injection combined with capsular distension (hydroplasty) and manipulation, which shows superior mid-term improvement at 3-4.5 months, though outcomes equalize by 6 months 8.
Safety Considerations
Diabetic Patients:
- Inform about transient hyperglycemia risk (days 1-3 post-injection)
- Advise glucose monitoring 9
Complication Rates (very low):
- Facial flushing: 1.78%
- Vasovagal reactions: 0.71%
- Chest/shoulder pain: 1.07%
- Nausea: 0.36% 1
Timing with Surgery: If joint replacement is eventually needed, perform injection at least 3 months prior to avoid infection risk 9.
Clinical Algorithm
- Confirm diagnosis through restricted passive ROM (not just active ROM) in multiple planes, particularly external rotation
- Stage the disease based on symptom duration and severity
- Refer for injection immediately if in Stage 1 (pain predominant, early stiffness) or Stage 2 (established stiffness)
- Prescribe concurrent physical therapy starting after injection
- Consider re-injection if initial response is good but symptoms recur (shared decision-making regarding benefits vs. risks) 9
The evidence is clear: corticosteroid injection accelerates recovery, reduces pain faster than oral medications, and improves function—especially when administered early in the disease course.